Moleculin Biotech

$3.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.19 (-5.23%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell MBRX and other stocks, options, and ETFs commission-free!

About MBRX

Moleculin Biotech, Inc. Common Stock, also called Moleculin Biotech, is a clinical stage pharmaceutical company, which engages in the development of treatments for highly resistant cancers and viruses.

CEO

Walter V. Klemp

Employees

Headquarters

Houston, Texas

Founded

2015

Market Cap

97.58M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.96M

High Today

$3.60

Low Today

$3.37

Open Price

$3.60

Volume

986.79K

52 Week High

$9.30

52 Week Low

$3.16

MBRX Earnings

-$0.20

-$0.13

-$0.07

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 10, Pre-Market